Categories Technology

Citron sends a shockwave: Panicked investors dump Shopify

Shopify (NYSE: SHOP) stock was trending during intra-day trading on Thursday, with over 2.87 million shares changing hands. The high-volume sell-off was spurred by bearish outlook given by research firm Citron on the stock.

Setting the 12-month price target on the stock at $100, Citron said it sees “drastic changes” in Shopify’s competitive landscape, which could hinder the company’s growth prospects.

The research firm was referring to reports that bigger tech firms including Microsoft (MSFT) or Facebook (FB) could soon be bringing out similar services, which in turn would eat into Shopify’s market share.

The short recommendation sent SHOP shares down over 6%. In the trailing 52 weeks period, the stock has gained 61%.

READ: LYFT AND SIX OTHER COMPANIES WENT PUBLIC IN MARCH. FULL LIST

This is the second time in the past three years that SHOP shares have suffered due to caution from Citron. The first stock plummet happened in the rear half of 2017. However, the stock rebounded soon after, thanks to the confidence of institutional investors including BNY Mellon, T. Rowe Price, and Fidelity Investments.

Investors have recently been worried about the deceleration in Shopify’s top line. In February, despite reporting market-beating fourth-quarter results, shares of Shopify (SHOP) fell over 6%, on the same reason.

Revenue for the quarter jumped 54% to $343.9 million, beating the market consensus. But the 54% increase in Q4 revenue marks the fourth consecutive quarter of growth rate decline. Revenue growth has consistently declined in the past three quarters, registering at 68% in Q1, 62% in Q2 and 58% in Q3.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top